Search Results 1531-1540 of 18340 for Topical

1. A Study to Analyze CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma - Mayo Clinic

   Replacement doses, topical, ophthalmologic, and inhalational steroids are permitted;; Stress-dose corticosteroids will be required in subjects with adrenal ...

2. RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC - Mayo Clinic

   Conditions requiring treatment with immunosuppressive medications within 30 days. Inhaled or topical steroids, and adrenal replacement steroid dose are ...

3. A Study to Determine Recommended Dose, Regimen and Evaluate the Safety and Preliminary Effectiveness of CC-92480 in Combination With Standard Treatments in Subjects with Relapsed or Refractory Multiple Myeloma (RRMM) and Newly Diagnosed Multiple Myeloma (NDMM) - Mayo Clinic

   Participation eligibility · Intranasal, inhaled, topical or local corticosteroid injections (e.g., intra-articular injection); · Systemic corticosteroids at doses ...

4. Advancing patient care through glaucoma research - Mayo Clinic

   Although topical therapeutics are typically first-line treatments for patients with glaucoma, less than 50% of patients take drops as prescribed. Sustained ...

5. Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors - Mayo Clinic

   Participation eligibility · Adrenal replacement (dose of ≤10 mg daily of prednisone or equivalent); · Topical, ocular, intra-articular, intranasal, or ...

6. Study to Evaluate Efficacy and Safety of Romosozumab Compared With Bisphosphonates in Children and Adolescents With Osteogenesis Imperfecta - Mayo Clinic

   Topical and inhaled glucocorticoids will be allowed. - Growth hormone (participants on stable dose of growth hormone for at least 3-months prior to ...

7. Bronchoscopy - Mayo Clinic

   Complications may be related to the procedure itself or to the sedative or topical numbing medicine. Bleeding. Bleeding is more likely if a biopsy was taken ...

8. A Study of TAK-981 in Combination with Rituximab in Participants with Relapsed/Refractory (r/r) CD20-positive (CD20+) Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

   ... topical steroid use, or as premedication for administration of study drug or contrast. Participants requiring steroids at daily doses > 20 mg prednisone ...

9. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   Use of topical or inhaled steroids is acceptable. Concomitant oral anticoagulant therapy or low molecular weight heparin (LMWH) (low dose aspirin is allowed) ...

10. Study to Determine the Effectiveness and Safety of Dupilumab in Adult and Adolescent Patients With Eosinophilic Esophagitis (EoE) - Mayo Clinic

    Treatment with swallowed topical corticosteroids within 8 weeks prior to baseline. Initiation, discontinuation, or change in the dosage regimen of the ...